InvestWiser

Revenio Group Corporation

REG1VNasdaq HelsinkiHealthcareMarket value 391 m EUR
9.29EUR −0.6%
last day · Price as of 18 November 2026

The answer first

Does Revenio Group beat the market?

No, Revenio Group has not beaten the market over the last year.

Revenio Group−58.1%Helsinki (OMXHGI)+15.3%
  • The ranking · Quality, value and trend combined

    Better than 34% of Nordic stocks

    • Quality68
    • Value56
    • Trend7

    No. 94 of 195 in healthcare

  • Expectations in the price

    Moderate expectations

    For the share to return about 9% a year from today's price, the cash Revenio Group keeps must grow about 7% a year for 10 years.

Max for seven days

Follow Revenio Group with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Revenio Group

From today, at a price of 9.29 EUR. Write why you follow Revenio Group, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Revenio Group

Your first answer is free, no account needed.

Do you own Revenio Group, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Revenio Group and a few more. Free, no card.

Past year against the exchange and Super Stock
Revenio Group−58.1%Helsinki (OMXHGI)+15.3%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Revenio Group has fallen 58.1% over the past year, including dividends.
  • Overall, Revenio Group ranks better than 34% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 74.4%. The price is 86.3% below its peak now.

What do analysts think of Revenio Group?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

34

Quality, value and trend together. Better than 34% of Nordic stocks.

No. 94 of 195 in healthcare

Quality68
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 89 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.94
  • Asset turnoverSales divided by everything the company owns0.33
  • Return on equityProfit divided by equity+7.7%
  • Cash conversionOperating cash flow divided by profit1.38

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value56
The price · Valuation: the multiples

Medium Fair price: about the same as a typical Nordic stock.

No. 39 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity1.7
  • P/SPrice divided by sales1.7
  • P/EPrice divided by earnings21.9
  • P/CFPrice divided by operating cash flow15.8

The ranking is built on P/E, P/B and P/S.

Trend7
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 166 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−36.9%
  • 6 months−34.5%
  • 9 months−49.6%
  • 12 months−58.1%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−16.0%
3 years, per year
−24.9%
5 years, per year
−30.0%
10 years, per year
+2.3%
Largest fall, 3 years
−74.4%
From a peak to the bottom
From the peak now
−86.3%
How far the price is from the peak
Volatility, 1 year
46.7%
How much the price swings over a year
Beta, 1 year
0.37
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Revenio Group

7 funds we follow own Revenio Group. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden6

From the funds' latest known holdings.

About Revenio Group

Revenio Group Corporation is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 760 employees.

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by veterinarians, ophthalmologists and other personnel to measure intraocular pressure in animal patients.

See the full analysis of Revenio Group.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Helsinki

Explore the stock market